A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
NCT00002138
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Sarcoma, Kaposi
HIV Infections
Interventions
DRUG:
Tecogalan sodium
Sponsor
Daiichi Pharmaceuticals